PE20399A1 - MUTEINA OB - Google Patents

MUTEINA OB

Info

Publication number
PE20399A1
PE20399A1 PE00108697A PE00108697A PE20399A1 PE 20399 A1 PE20399 A1 PE 20399A1 PE 00108697 A PE00108697 A PE 00108697A PE 00108697 A PE00108697 A PE 00108697A PE 20399 A1 PE20399 A1 PE 20399A1
Authority
PE
Peru
Prior art keywords
muteina
muteins
making
methods
relates
Prior art date
Application number
PE00108697A
Other languages
Spanish (es)
Inventor
Yves Guisez
Rene Devos
Geert Plaetinck
Der Heyden Jose Van
Sandra Verploegen
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20399A1 publication Critical patent/PE20399A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Abstract

The present invention relates to ob muteins, to DNA sequences coding for these ob muteins and methods for making these.
PE00108697A 1996-12-06 1997-12-02 MUTEINA OB PE20399A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96119606 1996-12-06

Publications (1)

Publication Number Publication Date
PE20399A1 true PE20399A1 (en) 1999-03-05

Family

ID=8223476

Family Applications (1)

Application Number Title Priority Date Filing Date
PE00108697A PE20399A1 (en) 1996-12-06 1997-12-02 MUTEINA OB

Country Status (8)

Country Link
AR (1) AR010333A1 (en)
AU (1) AU5654998A (en)
CO (1) CO4930295A1 (en)
HR (1) HRP970654A2 (en)
MA (1) MA24411A1 (en)
PE (1) PE20399A1 (en)
WO (1) WO1998024896A2 (en)
ZA (1) ZA9710832B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777388B1 (en) 1998-08-21 2004-08-17 Clf Medical Technology Acceleration Program, Inc. Leptin-related peptides
US7208572B2 (en) 1998-08-21 2007-04-24 Albany Medical College Leptin-related peptides
US6420339B1 (en) * 1998-10-14 2002-07-16 Amgen Inc. Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
US8227408B2 (en) 2005-09-07 2012-07-24 Neurotez, Inc. Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
CA2725143A1 (en) 2008-05-21 2009-11-26 Neurotez, Inc. Methods for treating progressive cognitive disorders related to neurofibrillary tangles
EP2352510A4 (en) 2008-11-04 2012-08-29 Neurotez Inc Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta
CA3138758A1 (en) 2010-09-28 2012-04-19 Amylin Pharmaceuticals, Llc Highly soluble leptins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0137234B1 (en) * 1983-08-17 1990-10-10 The Wellcome Foundation Limited Physiologically active compositions
US6309853B1 (en) * 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
WO1996023517A1 (en) * 1995-01-31 1996-08-08 Eli Lilly And Company Anti-obesity proteins
GB9509164D0 (en) * 1995-05-05 1995-06-28 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
MA24411A1 (en) 1998-07-01
AR010333A1 (en) 2000-06-07
WO1998024896A2 (en) 1998-06-11
CO4930295A1 (en) 2000-06-27
AU5654998A (en) 1998-06-29
WO1998024896A3 (en) 1998-10-01
ZA9710832B (en) 1998-06-08
HRP970654A2 (en) 1998-10-31

Similar Documents

Publication Publication Date Title
TR200100056T2 (en) Neurotrophic factors
ATE252639T1 (en) MODIFIED FACTOR AFFECTING DORSAL TISSUE
ID18249A (en) SUBSTITUTE 6.5-HETERO-BISICLIC SUBSTITUTED
GB9818916D0 (en) Use
NL1007590A1 (en) Hydroxyphenyltriazines.
ID17980A (en) PIRIMIDO OR SUBSIDIZED PYRIDO THAT CONTAINS 6,6-OR 6,7-BISICLIS
NL1007031A1 (en) Hydroxyphenyltriazines.
TR199601002A1 (en) 2-Oxo- and 2-thio-1, 2-dihydroquinolinyl-oxazolidinones.
DK0901488T3 (en) 2,4-Diamino
PE20399A1 (en) MUTEINA OB
DK0929299T3 (en) Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and 2-aminocyclohepta- (b) benzofurans
IL139604A0 (en) Novel peptides
SE9602822D0 (en) New receptor
ID19571A (en) RAW 1.4-BUTANADIOL PURIFICATION PROCESS
DE69709173D1 (en) BELASTUNGSWALZENANORDNÜNG.
DE69930370D1 (en) TESTISSI-SPECIFIC, HUMAN PROTEINASE, SVPH1-8
DE59704842D1 (en) Terminal block, especially initiator-actuator terminal
FR2720419B1 (en) Artificial block.
IT1302971B1 (en) PRODUCTION PROCEDURE FOR HAMS, AND MEANS RELATING TO THE PROCEDURE
ES2122912A1 (en) Metalocarboxypeptidase inhibitors and derived molecules used as antitumor agents
ID16030A (en) PROCESS OF MAKING 1.5-BENZOTIAZEPIN DOWN
ATE348109T1 (en) THE PRV-1 GENE AND ITS USE
ITGE960040A0 (en) PENTAPEPTIDE.
ES1033200Y (en) FLASHLIGHT - CANDY.
ES1033500Y (en) BOX-EXHIBITOR.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal